D.C. Circuit: HHS Drug Price Disclosure Rule Runs Afoul Of APA
WASHINGTON, D.C. — The District of Columbia U.S. Circuit Court of Appeals on June 16 concluded that “there is no reasoned statutory basis” for a May 2019 rule by the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article